Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Paola Barbarino, CEO, Alzheimer’s Disease International, shares her perspective on what is to come in the Alzheimer’s disease space, particularly the impact of COVID-19 on the diagnosis of dementia and disruption in clinical trials. This interview was recorded during an online conference call with The Video Journal of Dementia (VJDementia).
We use necessary cookies to make this site work. Analytics, preference, and marketing cookies are used only if you choose to allow them. You can change your choice at any time. For more information view our Cookie Policy.